Limits of Detection Matter: New Challenges for SARS-CoV-2 Diagnostics and COVID-19 Patient Management - As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management. This webinar presented by 360Dx discusses establishing quantitative SARS-CoV-2 viral load testing, the clinical relevance of limits of detection and viral load, the need for universal standards to compare SARS-CoV-2 detection methods, and technologies used to advance reference materials for assay standardization.
New Challenges for SARS-CoV-2 Diagnostics: Viral Load Testing and Variant Strain Genotyping – Even as COVID-19 vaccines are being deployed around the world, the clinical laboratory will continue to play a major role this year helping to control the pandemic by diagnosing new infections and improving disease management. This webinar, presented as a part of the Labroots Coronavirus Virtual Event Series, discusses two critically important issues clinical labs are facing today: 1) SARS-CoV-2 viral load testing and the clinical correlates and 2) early detection of new strains that are more infectious or more pathogenic using genotyping assays.
SARS-CoV-2 Testing Today and a New Serology Approach for High Throughput Screening – Presented as a part of the Labroots Coronavirus Virtual Event Series, this three part webinar discusses the ongoing challenges clinical laboratories are facing today with respect to viral SARS-CoV-2 RNA testing and introduces a new serology approach to impact the future of high throughput population screening. Presentations include: “Making Qualitative SARS-CoV-2 RNA Tests Quantitative”, “New Immunogenicity Strategies to Meet the Needs of a Developing Pandemic” and “SARS-CoV-2 Reference Materials for Assay Validation and QC”
How To Establish COVID-19 Diagnostics and Keep Up With Demand - In this presentation and panel Q&A, leading Clinical Laboratory Directors share their practical experiences and challenges faced when developing, validating and going live with a SARS-CoV-2 assay in routine diagnostics as well as address the challenges of ramping up testing to meet demand while maintaining quality standards.
Experience with SARS-CoV-2 (COVID-19) Assay Validation - In this 20 minute eCase Study you will hear first-hand how Dr. Jeff SoRelle and team, of the University of Texas Southwestern Medical Center, developed and validated a COVID-19 RT PCR assay. Jeff shares his decision to bring this development in house, how he chose reference materials, and he managed to scale up and provide rapid turnaround.
Rapid Implementation of SARS-CoV-2 Testing - Hear how Dr. Joel Lefferts and his team at the Dartmouth-Hitchcock Medical Center were able to rapidly increase, through automation, their SARS-CoV-2 assay on the Abbott M2000. Joel will provide practical experiences and challenges faced when developing, validating and going live with a SARS CoV-2 assay to facilitate patient testing.
Expert Advice Establishing a SARS-CoV-2 Assay for COVID-19 - Learn how Accuplex™ SARS-CoV-2 Reference Materials are meeting the immediate need and the critical role they play in validating the performance of Coronavirus Assay. The focus is on the technology, the importance of early detection and helping every lab accelerate go live launch.